Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

KCNH4


Suggest Content
Advertise Here
Gene DB Home
Symbol:KCNH4
Name(s):potassium voltage-gated channel, subfamily H (eag-related), member 4
Type:protein-coding
Organism:Homo sapiens
Synonyms:BEC2, ELK1, Kv12.3
Links: Pubmed, Entrez Gene, GeneCards, BioGPS, Map Viewer.

Recent Publications on KCNH4:

Pubmed Logo
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.
AIMS: This study reports the symptom and HRQOL results in which standard...
17th December, 2008
Quality of Life Department, European Organisation for Research and Eur J Cancer. 2008 Oct;44(15):2178-84.
DOI Direct Link
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
PURPOSE: Bec2 is an anti-idiotypic antibody that mimics GD3, a ganglioside...
3rd November, 2005
Division of Medical Oncology, Vrije Universiteit Medical Center, 1117 De J Clin Oncol. 2005 Oct 1;23(28):6854-64.
DOI Direct Link
A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside.
In previous studies, we showed that immunization with 2.5 mg of BEC2, an...
19th October, 2004
Clinical Immunology Service, Department of Medicine, Memorial Vaccine. 2004 Jul 29;22(21-22):2904-9.
DOI Direct Link
Distribution and functional properties of human KCNH8 (Elk1) potassium channels.
The Elk subfamily of the Eag K+ channel gene family is represented in...
6th January, 2004
Icagen, Inc., 4222 Emperor Blvd., Durham, NC 27703, USA. Am J Physiol Cell Physiol. 2003 Dec;285(6):C1356-66. Epub 2003 Jul 30.
DOI Direct Link
Lung cancer vaccines and gene therapy.
A number of cancer vaccine and gene therapy approaches are being evaluated...
3rd December, 2003
Cell Genesys, Inc., 500 Forbes Blvd., South San Francisco, CA 94080, USA. Lung Cancer. 2003 Aug;41 Suppl 1:S103-13.

View more research publications.

Clinical Trials:

Clinical Trials Logo
Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Patents:

Patents logo
US Patent No.Title
7447594 Molecular cardiotoxicology modeling
7276206 Electrical field stimulation of eukaryotic cells

KCNH4 results (if any) from reagent suppliers

Google CSE Logo
KCNH Antibody / KCNH Antibodies
KCNH4 shRNA Plasmid (m): sc-146364-SH. KCNH4 shRNA (m) Lentiviral Particles: sc- 146364-V. KCNH5 siRNA (h): sc-75370. KCNH5 shRNA Plasmid (h): sc-75370-SH ...
http://www.scbt.com/table-kcnh.html...

Thumbshot
KCNH4 siRNA (m) sc-146364
Click here for details. suitable control antibody: contact Technical Service for availability of control antibody; sqRT-PCR Primer also available: KCNH4 ...
http://www.scbt.com/ko/datasheet-146364-kcnh4-sirna-m.html...

Thumbshot

Search Bioportfolio and other Life Science Sites for KCNH4, or search for KCNH4 on BioPortfolio's antibody search engine.
This page has been viewed 85 times


Resources from the
NCBI used on this page, NCBI's standard disclaimer applies.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.